Suppr超能文献

侵袭性垂体肿瘤的病理学,特别涉及功能分类

Pathology of invasive pituitary tumors with special reference to functional classification.

作者信息

Scheithauer B W, Kovacs K T, Laws E R, Randall R V

出版信息

J Neurosurg. 1986 Dec;65(6):733-44. doi: 10.3171/jns.1986.65.6.0733.

Abstract

Pituitary adenomas may remain intrasellar or infiltrate dura and bone. Invasive adenomas are not considered to be malignant; in biological behavior they are between non-infiltrative adenomas and pituitary carcinomas. The latter are defined as tumors with subarachnoid, brain, or systemic metastasis. Invasion may be defined radiologically, operatively, or histologically. On the basis of operatively assessed tumor size and gross invasion of dura and bone as well as immunocytochemical and ultrastructural analysis of 365 pituitary adenomas, the following data were obtained. There were 23 growth hormone (GH)-cell adenomas: 14% microadenomas and 86% macroadenomas; their overall frequency of invasion was 50%. There were 24 prolactin (PRL)-cell adenomas: 33% microadenomas and 67% macroadenomas, with an overall frequency of invasion of 52%. Mixed GH-cell and PRL-cell adenomas were found in 35 cases; 26% were microadenomas and 74% were macroadenomas, and the overall frequency of invasion was 31%. Sixty patients had adrenocorticotropic hormone (ACTH)-cell adenomas (Cushing's disease): 87% microadenomas and 13% macroadenomas; the overall frequency of invasion was 25% (in 8% of microadenomas and 62% of macroadenomas). Twenty patients had ACTH-cell adenomas (Nelson's syndrome): 30% microadenomas and 70% macroadenomas; the overall frequency of invasion in these cases was 50% (in 17% of microadenomas and 64% of macroadenomas). Silent ACTH-cell adenomas, 100% macroadenomas, were found in 11 patients, with an 82% frequency of invasion. There were 32 follicle-stimulating and luteinizing hormone adenomas, all macroadenomas, with a frequency of invasion of 21%. Four patients had thyroid-stimulating hormone adenomas, all macroadenomas, with a 75% frequency of invasion. Null-cell adenomas were found in 93 cases: 2% microadenomas and 98% macroadenomas, with a frequency of invasion of 42%. There were 63 plurihormonal adenomas (GH, PRL, glycoprotein): 25% microadenomas and 75% macroadenomas, with a 50% overall frequency of invasion. Based on this study, and on their usual frequency of occurrence, the estimated rate of gross invasion by pituitary adenomas of all types is approximately 35%. It is concluded that immunocytochemical and ultrastructural characteristics of pituitary adenomas reflect the tendency of these tumors to infiltrate and hence may be of prognostic significance.

摘要

垂体腺瘤可局限于鞍内,也可侵犯硬脑膜和骨质。侵袭性腺瘤不被认为是恶性的;其生物学行为介于非侵袭性腺瘤和垂体癌之间。后者被定义为发生蛛网膜下腔、脑或全身转移的肿瘤。侵袭可通过影像学、手术或组织学来定义。根据手术评估的肿瘤大小、硬脑膜和骨质的大体侵犯情况以及对365例垂体腺瘤的免疫细胞化学和超微结构分析,获得了以下数据。有23例生长激素(GH)细胞腺瘤:14%为微腺瘤,86%为大腺瘤;其总体侵袭频率为50%。有24例催乳素(PRL)细胞腺瘤:33%为微腺瘤,67%为大腺瘤,总体侵袭频率为52%。发现35例混合性GH细胞和PRL细胞腺瘤;26%为微腺瘤,74%为大腺瘤,总体侵袭频率为31%。60例患者患有促肾上腺皮质激素(ACTH)细胞腺瘤(库欣病):87%为微腺瘤,13%为大腺瘤;总体侵袭频率为25%(微腺瘤为8%,大腺瘤为62%)。20例患者患有ACTH细胞腺瘤(尼尔森综合征):30%为微腺瘤,70%为大腺瘤;这些病例的总体侵袭频率为50%(微腺瘤为17%,大腺瘤为64%)。11例患者发现无功能ACTH细胞腺瘤,均为大腺瘤,侵袭频率为82%。有32例促卵泡生成素和促黄体生成素腺瘤,均为大腺瘤,侵袭频率为21%。4例患者患有促甲状腺激素腺瘤,均为大腺瘤,侵袭频率为75%。发现93例无功能细胞腺瘤:2%为微腺瘤,98%为大腺瘤,侵袭频率为42%。有63例多激素腺瘤(GH、PRL、糖蛋白):25%为微腺瘤,75%为大腺瘤,总体侵袭频率为50%。基于这项研究以及它们通常的发生率,估计所有类型垂体腺瘤的大体侵袭率约为35%。结论是垂体腺瘤的免疫细胞化学和超微结构特征反映了这些肿瘤的浸润倾向,因此可能具有预后意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验